CordovaCann Corp. (TSE:CDVA)
:CDVA
Want to see TSE:CDVA full AI Analyst Report?
Top Page
CordovaCann
(CDVA)
Select Model
Select Model
Rating:46Neutral
Price Target:
C$0.08
▲(290.00% Upside)
Action:ReiteratedDate:04/25/26
The score is held down primarily by high financial risk (negative equity and ongoing net losses) despite improved and positive free cash flow. Technicals are supportive with price above major moving averages, but overbought RSI increases near-term pullback risk. Valuation remains difficult to justify with a negative P/E and no dividend yield.
Positive Factors
Improved cash generation
CordovaCann has transitioned to positive operating and free cash flow across FY2024–FY2025 and TTM, producing roughly $0.86M FCF TTM. Sustained positive cash generation reduces reliance on external financing and supports operational continuity and reinvestment over the next several months.
Negative Factors
Negative shareholders' equity
A persistent negative shareholders' equity position materially limits financial flexibility and constrains access to capital markets. This structural balance sheet weakness increases creditor risk, may raise borrowing costs, and restricts the company's ability to fund growth or absorb shocks over months ahead.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved cash generation
CordovaCann has transitioned to positive operating and free cash flow across FY2024–FY2025 and TTM, producing roughly $0.86M FCF TTM. Sustained positive cash generation reduces reliance on external financing and supports operational continuity and reinvestment over the next several months.
Read all positive factors
CordovaCann (CDVA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$5.49M
Dividend YieldN/A
Average Volume (3M)44.87K
Price to Earnings (P/E)―
Beta (1Y)4.14
Revenue Growth-0.55%
EPS Growth-222.37%
CountryCA
Employees6
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding109,803,460
10 Day Avg. Volume14,141
30 Day Avg. Volume44,872
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-1.04
Price to Sales (P/S)0.42
P/FCF Ratio5.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CordovaCann Business Overview & Revenue Model
Company Description
CordovaCann Corp. engages in identifying, funding, developing, and managing operations in the cannabis value chain business. As of February 14, 2022, it operated 14 stores under the Star Buds Cannabis Co. brand in Ontario, Manitoba, Alberta, and B...
How the Company Makes Money
CordovaCann generates revenue by cultivating and producing cannabis products and distributing them to various retail outlets or directly through its own retail stores. The company may also earn income from the sale of ancillary products related to...
CordovaCann Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
18
Very Negative
Cash Flow
56
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.05M | 14.25M | 13.80M | 13.59M | 10.32M | 166.77K |
| Gross Profit | 2.36M | 1.55M | 4.08M | 3.86M | 3.49M | 60.03K |
| EBITDA | -1.13M | -817.35K | 493.74K | -4.68M | -2.69M | -4.00M |
| Net Income | -2.69M | -2.69M | -1.49M | -6.88M | -5.15M | -4.59M |
Balance Sheet | ||||||
| Total Assets | 6.48M | 6.41M | 9.55M | 10.26M | 17.27M | 14.69M |
| Cash, Cash Equivalents and Short-Term Investments | 586.03K | 598.20K | 552.47K | 248.42K | 1.06M | 647.74K |
| Total Debt | 5.20M | 5.00M | 6.21M | 6.38M | 5.91M | 5.61M |
| Total Liabilities | 11.94M | 11.61M | 12.15M | 11.29M | 9.96M | 8.42M |
| Stockholders Equity | -5.99M | -5.81M | -3.30M | -1.72M | 6.49M | 5.62M |
Cash Flow | ||||||
| Free Cash Flow | 856.49K | 1.12M | 1.49M | -1.21M | -962.15K | -1.18M |
| Operating Cash Flow | 873.17K | 1.14M | 1.49M | -452.73K | -221.16K | -1.04M |
| Investing Cash Flow | 1.55M | 1.55M | 52.96K | -708.88K | -872.05K | -145.59K |
| Financing Cash Flow | -2.51M | -2.51M | -1.10M | -134.36K | 1.57M | 1.72M |
CordovaCann Peers Comparison
UnderperformOutperform
Sector (51)
TSE:CDVA
CordovaCann
0.05
-0.02
-23.08%
TSE:BBM
Blueberries Medical
0.02
0.00
0.00%
TSE:BAMM
Body & Mind
0.03
0.00
0.00%
TSE:CVGR
City View Green Holdings
0.04
-0.06
-64.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.